To protect personal identifiers in cancer research and treatment, several measures are commonly employed:
De-identification: This involves removing or encrypting personal identifiers so that the data cannot be linked back to the individual without additional information. HIPAA Compliance: The Health Insurance Portability and Accountability Act (HIPAA) sets national standards for protecting sensitive patient data. Informed Consent: Patients are informed about how their data will be used and must give their explicit consent before any data is collected.
